Furthermore, flow cytometric analysis of single-cell suspensions from brain tissue of mice with IDH1-mutant gliomas displayed significantly fewer CD45+ immune cells compared with brain tissue of mice with wildtype Idh1 gliomas. This evidence concerns the gene PTPRC and central nervous system cancer.